Technology ❯ Artificial Intelligence

Drug Discovery

Biotechnology Innovation Clinical Trials Pharmaceutical Applications AI in Healthcare Generative AI AlphaFold Weight Loss Small-Molecule Inhibitors Pharmaceutical Industry Molecular Testing Predictive Modeling Health Applications Healthcare Innovation Software Development Collaborations Protein Design Peptide Technology Clinical Efficiency Antibiotics Peptide Prediction Molecule Testing Pharmaceuticals Biologics Development Healthcare Technology Computational Modeling Molecular Structure Prediction Machine Learning Healthcare Innovations AI Models Healthcare Applications Clinical Trial Efficiency Healthcare Recursion Pharmaceuticals Compound Screening Automation Molecular Synthesis Automated Research Platforms GPCR Research

Chai Discovery Raises $400 Million to Scale AI Drug Design

The mid‑July round and new Chai‑3 model signal faster, commercially deployed de novo antibody design that could reshape how big pharma finds drug candidates.

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Senhwa Signs MOU With GEM for Up to NT$500 Million to Speed AI-Driven Cancer R&D

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

Insilico, Qilu Strike Near-$120 Million AI Drug Discovery Pact for Cardiometabolic Therapies

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

AI-Designed Rentosertib Improves Lung Function in Phase IIa IPF Trial